Latest news with #HealthEquity
Yahoo
5 days ago
- Business
- Yahoo
HealthEquity Announces Dates to Report Second Quarter Earnings and Presentations at Investor Conferences
DRAPER, Utah, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ('HealthEquity' or the 'Company'), the nation's largest health savings account ('HSA") custodian, today announced plans to release its second quarter of fiscal 2026 financial results following the close of regular stock market trading hours on Tuesday, September 2, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, September 2, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's financial results. HealthEquity Second Quarter Fiscal Year 2026 Results Conference Call Date: September 2, 2025 Time: 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time Dial-In: 1-833-630-1956 (US and Canada) 1-412-317-1837 (International) Conference ID: HealthEquity Webcast: A replay of the conference call will be made available on the Company's website at The Company also announced that its management team plans to present and meet with investors at the following upcoming investor conferences: Wells Fargo 2025 Healthcare Conference Location: Encore Boston Harbor Hotel Date: September 3, 2025 Time: 8:00 a.m. Eastern Time Webcast: noneJefferies 2025 Fintech Conference Location: The Langham Hotel Date: September 4, 2025 Time: 10:40 a.m. Eastern Time Webcast: none Morgan Stanley 23rd Annual Global Healthcare Conference Location: Sheraton New York Times Square Date: September 8, 2025 Time: 10:45 a.m. Eastern Time Webcast: noneBaird 2025 Global Healthcare Conference Location: Intercontinental Barclay Hotel Date: September 9, 2025 Time: 2:00 p.m. Eastern Time Webcast: none Deutsche Bank's 2025 Healthcare Summit Location: Deutsche Bank Center Date: September 10, 2025 Time: One on One meetings only during the day Webcast: none About HealthEquity HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 17 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers who share our unwavering commitment to our mission of saving and improving lives by empowering healthcare consumers. Through cutting-edge solutions, innovation, and a relentless focus on improving health outcomes, we empower individuals to take control of their healthcare journey while ultimately enhancing their overall well-being. Learn more about our 'Purple' service and approach at Forward-looking statements This press release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words 'may,' 'believes,' 'intends,' 'seeks,' 'aims,' 'anticipates,' 'plans,' 'estimates,' 'expects,' 'should,' 'assumes,' 'continues,' 'could,' 'will,' 'future' and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release. Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following: our ability to adequately place and safeguard our custodial assets, or the failure of any of our depository or insurance company partners; our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry; our dependence on the continued availability and benefits of tax-advantaged HSAs and other CDBs; risks relating to our recent CEO transition; the impact of increased fraudulent account activity involving our member accounts or our third-party service providers on our reputation and financial results; our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets; the significant competition we face and may face in the future, including from those with greater resources than us; our reliance on the availability and performance of our technology and communications systems; recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business; the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations; potential regulatory changes and changes in the enforcement environment under the new U.S. administration; our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business; our reliance on partners and third-party vendors for distribution and important services; our ability to develop and implement updated features for our technology platforms and communications systems; and our reliance on our management team and key team members. For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended January 31, 2025. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release. Investor Relations Contact:Richard Putnam801-727-1000rputnam@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
04-08-2025
- Health
- Yahoo
Homestyle Direct Expands Access to Medically Tailored Meals in California
Delivering Nutritious Meals Across Five Counties TWIN FALLS, Idaho, Aug. 4, 2025 /PRNewswire/ -- Homestyle Direct is proud to announce its expansion into several new California markets. Through this expansion, Homestyle Direct will bring nutritious, medically tailored meal options to eligible Medi-Cal members in five counties, including Santa Clara, San Luis Obispo, Santa Barbara, San Bernardino, and Riverside. This growth marks a significant step in the company's mission to deliver delicious, healthy meal options that promote health equity, disease management, and food security. According to a growing body of evidence, insurance coverage for medically tailored meals is proving to be a smart investment for health insurers and a Health Friendly move for their members. For example, a 2024 study by the MANNA Institute found that medically tailored meals support better outcomes for patients with high blood pressure, high blood sugar, and obesity. Homestyle Direct's medically tailored meals are designed to deliver those benefits, right to members' doorsteps. With over 35 dietitian-approved options, members and case managers can easily find meals that meet a wide range of medical and dietary needs, including Diabetes Friendly, Heart Friendly, and Renal Friendly choices, as well as Power Packed meals for those who need foods that boost energy levels. The menu also includes Gluten Restricted and Vegetarian selections. "As the premier provider of medically tailored meals delivered to homes in more than 30 states, we're excited to bring our services to even more Californians," said Jeff Barteau, CEO of Homestyle Direct. "We believe that better health starts with better food, and we're proud to play a role in empowering people to manage their health through access to nutritious meals." Unlike similar programs, Homestyle Direct offers fast, reliable delivery through its national FedEx partnership, an easy ordering process, and responsive customer support. Members benefit from meals customized to their individual health needs and preferences, backed by a 97 percent satisfaction rate. To learn more about eligibility and begin ordering meals, visit Case managers and Foodsmart coaches can make referrals at Homestyle Direct can also be reached at 1-866-735-0004. About Homestyle DirectSince 1997, Homestyle Direct has been serving home-delivered meals to families across the U.S. Today, the company offers a wide variety of medically tailored meals to Medicaid and Medicare Advantage members, ensuring choice in every meal to support a healthy lifestyle and promote food security. Developed with a licensed dietitian, each meal balances taste, nutrition, choice, and convenience. California members under managed care programs receive meals fully covered by Medi-Cal or Medicare Advantage. To learn more, visit View original content to download multimedia: SOURCE Homestyle Direct Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-07-2025
- Business
- Yahoo
HealthEquity (NASDAQ:HQY) delivers shareholders respectable 12% CAGR over 5 years, surging 3.4% in the last week alone
The main point of investing for the long term is to make money. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the HealthEquity, Inc. (NASDAQ:HQY) share price is up 77% in the last five years, that's less than the market return. Some buyers are laughing, though, with an increase of 33% in the last year. The past week has proven to be lucrative for HealthEquity investors, so let's see if fundamentals drove the company's five-year performance. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During the five years of share price growth, HealthEquity moved from a loss to profitability. That's generally thought to be a genuine positive, so investors may expect to see an increasing share price. You can see below how EPS has changed over time (discover the exact values by clicking on the image). We know that HealthEquity has improved its bottom line over the last three years, but what does the future have in store? Take a more thorough look at HealthEquity's financial health with this free report on its balance sheet. A Different Perspective We're pleased to report that HealthEquity shareholders have received a total shareholder return of 33% over one year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 12% per year), it would seem that the stock's performance has improved in recent times. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for HealthEquity you should know about. If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-07-2025
- Business
- Yahoo
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum. Growth investors build their portfolios around companies that are financially strong and have a bright future, and the Growth Style Score helps take projected and historical earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth. Draper, UT-headquartered HealthEquity provides integrated solutions for healthcare account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HQY sits at a Zacks Rank #2 (Buy), holds a Growth Style Score of B, and has a VGM Score of B. Earnings and sales are forecasted to increase 19.6% and 8.5% year-over-year, respectively. Six analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.11 to $3.73 per share. HQY also boasts an average earnings surprise of 12.4%. HealthEquity is also cash rich. The company has generated cash flow growth of 19.3%, and is expected to report cash flow expansion of 25.9% in 2026. HQY should be on investors' short lists because of its impressive growth fundamentals, a good Zacks Rank, and strong Growth and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HealthEquity, Inc. (HQY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-07-2025
- Business
- Yahoo
HealthEquity (HQY) Upgraded to Buy: Here's Why
Investors might want to bet on HealthEquity (HQY), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements. Therefore, the Zacks rating upgrade for HealthEquity basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock. Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for HealthEquity imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher. Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions. The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> . This provider of services for managing health care accounts is expected to earn $3.73 per share for the fiscal year ending January 2026, which represents no year-over-year change. Analysts have been steadily raising their estimates for HealthEquity. Over the past three months, the Zacks Consensus Estimate for the company has increased 8.8%. Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term. You can learn more about the Zacks Rank here >>> The upgrade of HealthEquity to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HealthEquity, Inc. (HQY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
